In this retrospective study to assess the impact of serum corrected calcium
(CorrCa), magnesium (Mg) and phosphorus (P) levels, all adult patients with
laboratory-confirmed COVID-19 hospitalized during 2020 were included. Poor
outcome was considered in patients who presented need for mechanical
ventilation, intensive care unit (ICU) admission, or in-hospital mortality. We
analyzed 2473 patients (956 females) aged (mean±SD) 63.4±15.9
years. During admission, 169 patients (6.8%) required mechanical
ventilation, 205 (8.3%) were admitted to the ICU, and 270
(10.9%) died. Composite variable of poor outcome, defined as need for
mechanical ventilation, ICU admission or death, was present in 434
(17.5%) patients. In univariate analysis, the need for mechanical
ventilation was positively related to Mg levels (OR 8.37, 95% CI
3.62–19.33; p<0.001); ICU admission was related to CorrCa (OR
0.49, 95% CI 0.25–0.99; p=0.049) and Mg levels (OR 5.81,
95% CI 2.74–12.35; p<0.001); and in-hospital mortality
was related to CorrCa (OR 1.73, 95% CI 1.14–2.64;
p=0.011). The composite variable of poor outcome was only related to Mg
(OR 2.68, 95% CI 1.54–4.68; p=0.001). However, in
multivariate analysis only CorrCa was significantly related to the need for
mechanical ventilation (OR 0.19, 95% CI 0.05–0.72;
p=0.014) and ICU admission (OR 0.25; 95% CI 0.09–0.66;
p=0.005), but not with in-hospital mortality or the composite variable.
In conclusion, CorrCa can be used as a simple and reliable marker of poor
outcome in patients with COVID-19, although not to predict the risk of
in-hospital mortality.